NCT05734443

Brief Summary

The goal of this clinical trial is to evaluate a novel and pragmatic (i.e., not requiring specialized equipment) task-specific step training regimen that aims to improve reactive balance after tripping. The main questions it aims to answer are:

  • Does this step training regimen improve reactive balance after tripping compared to no training?
  • How well does this step training regimen improve reactive balance compared to treadmill training, which is a more commonly studied reactive balance training regimen that uses a specialized treadmill. Participants will:
  • complete step training or treadmill training (or no training if assigned to the control group) twice a week for three weeks
  • experience a laboratory-induced trip three weeks later to evaluate their reactive balance

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

September 24, 2025

Completed
Last Updated

September 24, 2025

Status Verified

September 1, 2023

Enrollment Period

9 months

First QC Date

February 8, 2023

Results QC Date

June 16, 2025

Last Update Submit

September 3, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Trunk Angle at Touchdown of the First Recovery Step

    After a laboratory-induced trip: Angle from vertical of a line connecting midpoint of greater trochanter markers and midpoint of the acromion markers

    1 week after the 3-week intervention

  • Trip Outcome

    This is a binary variable that has a value of either "fall" or "recovery." After a laboratory-induced trip, trip outcome will be assign to one of the following two values: "fall" if a participant is fully and continuously supported by the harness as observed from video, or if the harness force applied to the participant, integrated over time from trip onset until 1 second after touchdown of the first recovery step, is greater than 40% of body weight \* seconds. The harness force will be measured by a uniaxial load cell. "recovery" if the harness force applied to the participant, integrated over time from trip onset until 1 second after touchdown of the first recovery step, is less than 40% of body weight \* seconds. The harness force will be measured by a uniaxial load cell.

    1 week after the 3-week intervention

Secondary Outcomes (5)

  • Recovery Step Length

    1 week after the 3-week intervention

  • Sacrum Height at Touchdown of the First Recovery Step

    1 week after the 3-week intervention

  • Gait Speed

    1 week after the 3-week intervention

  • Average Step Speed

    1 week after the 3-week intervention

  • Trip Recovery Strategy

    1 week after the 3-week intervention

Study Arms (3)

step training

EXPERIMENTAL

Two training sessions per week will be completed for three consecutive weeks. Each training session will last 0.5-1 hour with an active training time of 30 minutes per participant. Training will involve repeated volitional and reactive stepping movements that mimic the movements necessary to recover balance after tripping while walking.

Behavioral: step training

treadmill training

EXPERIMENTAL

Two training sessions per week will be completed for three consecutive weeks. Each training session will last 0.5-1 hour with an active training time of 30 minutes per participant. Training will involve repeated exposure to simulated trips on a treadmill. To simulate a trip, participants first stand on the stationary treadmill belt. A sudden and unexpected increase in backward treadmill belt speed induces a forward loss of balance similar to when tripping. Participants are then required to take steps to recover balance and establish a stable gait pattern before the trial ends. Trials are repeated using pseudo-random speeds that provide variability and are individualized to each participant's capabilities.

Behavioral: treadmill training

Control

NO INTERVENTION

Interventions

step trainingBEHAVIORAL

Participants practice volitional and reactive stepping responses that mimic those needed when recovering balance after tripping.

step training

Sudden treadmill changes in speed (from standing) induce trip-like losses of balance, after which participants take steps to recover balance and establish a stable gait pattern. This is repeated over a range of speeds to both provide training variability and to individualize training to each participant's capability.

treadmill training

Eligibility Criteria

Age65 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • years old
  • willing to use wearable sensors for 2-3 weeks (for a separate study)
  • no lower limb amputation
  • not weigh over 250 pounds
  • pass a telephone interview related to cognitive status

You may not qualify if:

  • participants must pass a health screening involving a questionnaire that will be reviewed by a health care specialist.
  • participants must not have clinical osteoporosis as indicated by a bone mineral density of the lumbar vertebra and proximal femur of t\<-2.0 as obtained from dual energy x-ray absorptiometry (DEXA), or a DEXA scan completed within the last year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Tech

Blacksburg, Virginia, 24061, United States

Location

Results Point of Contact

Title
Michael Madigan
Organization
Virginia Tech

Study Officials

  • Michael L. Madigan, PhD

    Virginia Polytechnic Institute and State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2023

First Posted

February 21, 2023

Study Start

November 1, 2022

Primary Completion

August 1, 2023

Study Completion

August 1, 2023

Last Updated

September 24, 2025

Results First Posted

September 24, 2025

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations